Akebia Therapeutics (AKBA) Non-Current Debt (2019 - 2026)
Akebia Therapeutics' Non-Current Debt was $24.75 million in Q2 2026, down 47.4% from $47.06 million a year earlier and down 32.0% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Non-Current Debt (2019 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Debt at Akebia Therapeutics came in at $48.25 million, up 24.7% from FY2024.
- Non-Current Debt shows a five-year compound annual growth rate of -12.9% (FY2020 to FY2025).
- In earlier years, Non-Current Debt was $38.69 million in FY2024 (+125.2%), $17.18 million in FY2023 (-49.6%) and $34.08 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non-Current Debt since Q4 2023.
- Compared with a year earlier, Non-Current Debt was higher in six of the last eight quarters, with growth averaging 24.2%.
- The best year-over-year quarter for Non-Current Debt over five years was Q4 2024 (growth of 125.2%); the worst was Q4 2023 (a decline of 49.6%).
- Per Business Quant data, AKBA's Non-Current Debt in the three quarters before Q2 2026 was $36.4 million (Q1 2026), $48.25 million (Q4 2025) and $47.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 24.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.75 Mn |
| Mar 31, 2026 | 36.40 Mn |
| Dec 31, 2025 | 48.25 Mn |
| Sep 30, 2025 | 47.64 Mn |
| Jun 30, 2025 | 47.06 Mn |
| Mar 31, 2025 | 46.51 Mn |
| Dec 31, 2024 | 38.69 Mn |
| Sep 30, 2024 | 38.36 Mn |
| Jun 30, 2024 | 38.03 Mn |
| Mar 31, 2024 | 30.15 Mn |
| Dec 31, 2023 | 17.18 Mn |
| Sep 30, 2023 | 34.61 Mn |
| Jun 30, 2023 | 18.49 Mn |
| Mar 31, 2023 | 26.30 Mn |
| Dec 31, 2022 | 34.08 Mn |
| Sep 30, 2021 | 97.23 Mn |
| Jun 30, 2021 | 96.92 Mn |
| Mar 31, 2021 | 96.61 Mn |
| Dec 31, 2020 | 96.38 Mn |
| Sep 30, 2020 | 76.61 Mn |
API Access
Akebia Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();